Myron M. Gellman

Myron Gellman has spent more than thirty years helping private companies through complex business transitions, including mergers and acquisitions. His wealth of experience spans strategic planning, succession and exit planning, and executive advisory services, making him an ideal resource for any business preparing for such a change. Myron is uniquely able to:

• Develop strategic plans to position companies for optimal valuation
• Guide CEOs and boards through the complexities of M&A decisions, challenging them to think differently about their businesses
• Navigate the intricate dynamics of stakeholder relationships during transactions

Identify and resolve underlying issues that could impact deal value or post-merger integration. Myron’s creative problem-solving skills and strategic insight are particularly valuable for businesses looking to buy or sell. He excels at:

• Crafting innovative deal structures that maximize value for all parties
• Developing succession and exit strategies that align with long-term business goals
• Providing critical advisory services to ensure smooth leadership transitions post-acquisition
• Offering unique perspectives that often uncover hidden opportunities in transactions
• Facilitating ‘corporate therapy’ sessions that help business partners and families resolve their differences and move forward together

Myron’s approach to M&A is characterized by his unwavering persistence and dedication to achieving optimal outcomes. His mantra, “never never never give up,” drives him to overcome obstacles and find solutions in even the most challenging transactions. His commitment to mentorship and knowledge-sharing enriches the entire Mercadien team, ensuring that clients benefit from a depth of expertise across all aspects of the M&A process. With Myron’s strategic vision and proven track record in business transformation, clients of Mercadien gain a trusted advisor who can guide them through every stage of the M&A journey, from initial strategic planning to post-deal success.